This article was originally published on this site
It was a tough day for Theratechnologies Inc. (TH:CA) as its stock fell 11.46% to finish the day at $6.49 a share on November 14. That reduces the company’s market cap to 486.25 million on 74.92 million outstanding shares. Theratechnologies Inc. is a component of the the S&P/TSX SmallCap Index.
694,451 shares exchanged hands over the course of the day as compared with an average daily volume of 73,375 over the last 30 days.
Theratechnologies Inc is a specialty pharmaceutical company addressing unmet medical needs to promote healthy ageing and an improved quality of life among HIV patients.. Theratechnologies Inc. makes its home in Montreal, QC, and currently has CEO Luc Tanguay at the helm.
The past 52 weeks have seen the stock trade in a range between a high of $8.72 and a low of $2.61, and it’s currently sporting a 50-day SMA of $7.61 and a 200-day SMA of $6.73. The current P/E ratio stands at 0, with a P/B ratio of 10.64.
Want to invest with the experts? Subscribe to Equities Premium newsletters today! Visit http://www.equitiespremium.com/ to learn more about Guild Investment’s Market Commentary and Adam Sarhan’s Find Leading Stocks today.
Theratechnologies Inc. ($TH:CA) is one of the 200 Canadian small-cap stocks that make up the S&P500/TSX SmallCap Index, the widely recognized benchmark for gauging the performance of the Canadian small-cap market. Similar to the Russell 2000 in the United States, the index is market cap-weighted and consists only of smaller companies. To be a part of the index, a company must have a market capitalization between C$100 million and C$1.5 billion with an average share price of C$1 or more.
To get more information on Theratechnologies Inc. and to follow the company’s latest updates, you can visit the company’s profile page here: TH:CA’s Profile. For more news on the financial markets and emerging growth companies, be sure to visit Equities.com’s Newsdesk. Also, don’t forget to sign-up for our daily email newsletter to ensure you don’t miss out on any of our best stories.
All data provided by QuoteMedia and was accurate as of 4:30PM ET.
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer